IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
According to IM Cannabis Corp.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.45. At the end of 2022 the company had a P/B ratio of 2.47.
Year | P/B ratio |
---|---|
2023 | 2.45 |
2022 | 2.47 |
2021 | 0.57 |
2020 | 211.85 |
2019 | 10.58 |
2018 | -157.50 |
2017 | 0.06 |
2016 | 0.05 |
2015 | 0.05 |
2014 | 0.27 |
2013 | 1.00 |
2012 | 4.67 |
2011 | 7.05 |
2010 | 12.20 |
2009 | 8.46 |
2008 | 11.89 |
2007 | 22.24 |
2006 | 26.11 |
2005 | 27.00 |
2004 | 12.74 |
2003 | 19.65 |
2002 | 0.00 |
2001 | 0.00 |
2000 | 0.00 |
1999 | 0.00 |
1998 | 0.00 |
1997 | 0.00 |
1996 | 0.00 |